|
|
|
Press Releases
All Releases
 |
Vision-Sciences, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 2nd
Feb 1, 2012
|
7.3 KB |
|
| |
ORANGEBURG, N.Y., Feb. 1, 2012 /PRNewswire/ -- Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of innovative flexible endoscopic products utilizing proprietary sterile disposable EndoSheath® technology, today announced its participation at RetailInvestorConferences.com.
DATE: February 2, 2012
TIME: 2:30 PM EST
...
|
|
Vision-Sciences Reports Record Third Quarter Fiscal 2012 Net Sales of $4.3 Million
Jan 31, 2012
|
1.1 MB |
|
| |
Third Quarter Highlights
Third quarter fiscal 2012 net sales increased 59% to $4.3 million from $2.7 million in third quarter fiscal 2011
Medical segment sales increased 73%, driven by higher urology and pulmonology sales
Gross profit increased 68% to $1.4 million, driven by favorable business mix...
|
|
Vision-Sciences Announces Release Date of Third Quarter Fiscal 2012 Results
Jan 24, 2012
|
9.4 KB |
|
| |
ORANGEBURG, N.Y.--(BUSINESS WIRE)-- Vision-Sciences, Inc. (NASDAQ: VSCI - News), a leading provider of unique
flexible endoscopic products utilizing sterile disposable sheaths, today
announced that it will release its financial results for its third
quarter e...
|
|
Vision-Sciences, Inc. to Present at Lazard Healthcare Conference on November 16, 2011
Nov 10, 2011
|
7.2 KB |
|
| |
ORANGEBURG, N.Y., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced that executive management will present at the Lazard Capital Markets Healthcare Conference to be held November 15-16, 2011 in New York, NY. Cynthia Ansari, Chief Executive Officer, and Katherine Wolf, CFO & EVP Corporate Development, are schedule...
|
|
Vision-Sciences, Inc. Announces Net Sales Growth of 73% to $4.0 Million for the Second Quarter of Fiscal 2012
Nov 7, 2011
|
23.9 KB |
|
| |
ORANGEBURG, N.Y., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for its second quarter and first half of fiscal 2012, ended September 30, 2011. The financial results were as follows:Second Quarter and First Half Highlights
Net sales increased 73% to $4.0 million in the second quarter and...
|
|
Vision-Sciences, Inc. Schedules Second Quarter and First Half of Fiscal 2012 Conference Call for November 8, 2011
Nov 2, 2011
|
8.5 KB |
|
| |
ORANGEBURG, N.Y., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) will issue financial results for the second quarter and first half of fiscal 2012, ended September 30, 2011, after the market closes on November 7, 2011. Vision-Sciences will host a conference call to discuss second quarter and first half of fiscal 2012 financia...
|
|
Vision-Sciences' Pioneering Technology Featured on The Doctor Oz Show
Sep 19, 2011
|
10.7 KB |
|
| |
ORANGEBURG, N.Y., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today that its unique, advanced Transnasal EndoSheath® Esophagoscopy system will be featured on the September 20th episode of "The Doctor Oz Show" during a segment addressing esophageal cancer, the fastest growing cancer in America and Europe.
...
|
|
Vision-Sciences, Inc. Appoints Cynthia F. Ansari Chief Executive Officer
Aug 10, 2011
|
8.3 KB |
|
| |
ORANGEBURG, N.Y., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) announced today that its Board of Directors has named Cynthia F. Ansari as Chief Executive Officer and elected her to the Board of Directors. Ms. Ansari replaces Warren Bielke, Interim Chief Executive Officer, who will be serving as Director of Strategic Initia...
|
|
Vision-Sciences, Inc. Announces $3.8 Million in Revenue for the First Quarter of Fiscal 2012
Aug 10, 2011
|
21.2 KB |
|
| |
ORANGEBURG, N.Y., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for its first quarter of fiscal 2012, ended June 30, 2011. For the first quarter of fiscal 2012, net sales were $3.8 million, an increase of $1.1 million, or 43%, from the first quarter of fiscal 2011, ended June 30, 2010, prima...
|
|
Vision-Sciences, Inc. Schedules Fiscal 2012 Conference Call for August 11, 2011
Aug 8, 2011
|
8.4 KB |
|
| |
ORANGEBURG, N.Y., Aug. 8, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) will issue financial results for the first quarter of fiscal 2012, ended June 30, 2011, after the market closes on August 10, 2011. Vision-Sciences will host a conference call to discuss first quarter of fiscal 2012 financial results and provide an update on the ...
|
|
Vision-Sciences, Inc. Announces Revenue of $3.2 Million for Fourth Quarter and $10.9 Million for Full Year Fiscal 2011
Jun 2, 2011
|
27.1 KB |
|
| |
ORANGEBURG, N.Y., June 2, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for its fourth quarter and full year fiscal 2011, ended March 31, 2011. For the fourth quarter of fiscal 2011, net sales were $3.2 million, an increase of $1.2 million, or 61%, from the fourth quarter of fiscal 2010, ended March ...
|
|
Vision-Sciences Signs Three Year Supply Agreement With Novation to Provide Unique EndoSheath Endoscopy Systems
Jun 2, 2011
|
10.5 KB |
|
| |
ORANGEBURG, N.Y., June 2, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the signing of a comprehensive three-year equipment supply agreement with Novation LLC, one of the nation's largest group purchasing organizations (GPO). This agreement will allow the members of VHA Inc., University HealthSystem Consortium (UHC) a...
|
|
Vision-Sciences, Inc. Schedules Fiscal 2011 Conference Call for June 3, 2011
Jun 1, 2011
|
8.5 KB |
|
| |
ORANGEBURG, N.Y., June 1, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) will issue financial results for the fourth quarter and full year fiscal 2011, ended March 31, 2011, after the market closes on June 2, 2011. Vision-Sciences will host a conference call to discuss fourth quarter and full year fiscal 2011 financial results and pr...
|
|
Vision-Sciences' EndoSheath Cystoscopy Technology to be Introduced by Stryker at Largest Urology Conference in North America
May 13, 2011
|
10.7 KB |
|
| |
ORANGEBURG, N.Y., May 13, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the introduction by Stryker Corporation ("Stryker") of the new line of EndoSheath Cystoscopy products at the 106th Annual American Urological Association (AUA) Meeting in Washington D.C. beginning Saturday, May14, 2011. Over 10,000 participants at...
|
|
Vision-Sciences, Inc. Clarifies Recent Stock Dispositions; Announces Positive Progress
Apr 6, 2011
|
8.7 KB |
|
| |
ORANGEBURG, N.Y., April 6, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today clarified that recent beneficial ownership reports filed yesterday with the SEC on Form 4 on behalf of certain members of its management team did not reflect any actual sales of company shares held by management. These reports were timely filed to reflect ...
|
|
Vision-Sciences, Inc. Announces $7.7 Million in Revenue for the First Nine Months of Fiscal 2011
Feb 9, 2011
|
26.6 KB |
|
| |
ORANGEBURG, N.Y., Feb. 9, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced results for its third quarter and first nine months of fiscal 2011, ended December 31, 2010. For the third quarter of fiscal 2011, net sales were $2.7 million, a sequential increase of $0.4 million, or 17%, from the second quarter of fiscal 2011, ...
|
|
Vision-Sciences, Inc. Schedules Fiscal Q3 2011 Conference Call for February 10, 2011
Feb 4, 2011
|
7.0 KB |
|
| |
ORANGEBURG, N.Y., Feb. 4, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) (Vision-Sciences) will issue results for the third quarter and first nine months of its fiscal year 2011 ended December 31, 2010 after the market closes on February 9, 2011. Vision-Sciences will host a conference call to discuss third quarter and first nine mont...
|
|
Vision-Sciences, Inc. Announces Completion of $10.5 Million Common Stock Private Placement; $2.7 Million in Revenue for the Third Quarter of Fiscal 2011
Jan 18, 2011
|
7.7 KB |
|
| |
ORANGEBURG, N.Y., Jan. 18, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) (Vision-Sciences), announced today that it entered into common stock purchase agreements with a limited number of private investors for the sale of 7 million shares of Vision-Sciences' Common Stock at a purchase price of $1.50 per share, for a total cash consid...
|
|
Vision-Sciences, Inc. Announces Election of New Director
Dec 15, 2010
|
8.9 KB |
|
| |
ORANGEBURG, N.Y., Dec. 15, 2010 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) (Vision-Sciences), announced today that its Board of Directors elected Dr. Bruce Polsky to serve as a member of its Board, effective immediately. Dr. Polsky will be an independent member of the Board.
"I am extremely pleased to welcome Bruce to the Board. H...
|
|
Vision-Sciences, Inc. Announces $5.0 Million in Revenue for the First Half of Fiscal 2011
Nov 10, 2010
|
24.9 KB |
|
| |
ORANGEBURG, N.Y., Nov. 10, 2010 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced results for its second quarter and first half of fiscal 2011, ended September 30, 2010. For the second quarter of fiscal 2011, net sales were $2.3 million, a decrease of $0.6 million, or 20%, from the second quarter of fiscal 2010, ended Septembe...
|
|
|
= add release to Briefcase |
| |
| |
|
|
|
